KY-41111

N/A

Report date: 2024/11/07 16:41:43
NME

Base Information

Drug NameKY-41111
Drug Alias NameKY-41111
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionThyroid hormone receptor beta agonists
TargetsThyroid hormone receptor beta
Therapy Area/IndicationsMetabolic Dysfunction-Associated Steatotic Liver Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesKpc Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesKpc Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsMetabolic Dysfunction-Associated Steatotic Liver Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A